Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ms. Sjogren brings nearly 30 years of biopharmaceutical experience building commercial organizations and leading successful oncology launches Pending acquisition of AnHeart Therapeutics and...
AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer...
Nearly three months into 2024, it’s clear that the bullish trends are here to stay. Markets hit a bottom in late October, but since then the S&P 500 has gained 27% and now stands at more than 5,200. The NASDAQ index is up 30% from its own October 27 low point. These are bull-market numbers, and show little sign of stopping. Watching the market from Oppenheimer, chief investment strategist John Stoltzfus comments on the market outlook: “S&P 500 earnings results over the most recent two quarterly
Both Metro and ODOT have been studying the idea of tolling on the west side for a few years. They began meeting with local officials in 2022.
Half Yearly Report - 31 December 2023 Kazia Therapeutics Limited ...